Healthlead PCL

Healthlead PCL Forward P/E

The Forward P/E Ratio of Healthlead PCL (HL.BK) as of Nov 11, 2026 is 25.15. In the previous year, Forward P/E Ratio was 25.02 — a change of 0.52% (higher).

Forward P/E

25.15

YoY

0.52%

Last updated:

Forward P/E Ratio of Healthlead PCL is 2025 25.15 . Forward P/E Ratio of Healthlead PCL was 2024 25.02 . It decreases by 0.52% higher compared to the previous year.

The Healthlead PCL Forward P/E history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Forward P/E
Date
Forward P/E
Jan 1, 2018
5,029.26 THB
Jan 1, 2019
89.97 THB
Jan 1, 2020
37.61 THB
Jan 1, 2021
24.58 THB
Jan 1, 2022
16.56 THB
Jan 1, 2023
26.22 THB
Jan 1, 2024
25.02 THB
Jan 1, 2025
25.15 THB
The Healthlead PCL Forward P/E history
YEARForward P/EYoY
25.15+0.52%
25.02-4.58%
26.22+58.32%
16.56-32.62%
24.58-34.63%
37.61-58.20%
89.97-98.21%
5,029.26-2,478.69%
-211.43—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Healthlead PCL Stock analysis

What does Healthlead PCL do? Healthlead PCL operates pharmacies under four brands: Icare, Pharmax, vitaminclub, and Super Drug. The company distributes medicines, medical supplies, cosmeceuticals, dietary supplements, medical equipment, and other health products through these branded outlets. It sells over 10,000 SKUs of healthcare items including medicines, supplements, and medical devices to meet diverse customer demands. The PRIME brand offers dietary supplements as part of its product portfolio. The company's revenue streams come from pharmacy sales across its four brand names and the distribution of healthcare products. Its subsidiaries handle the invention, development, importing, and distribution of medical supplies and health-related goods. Healthlead PCL targets retail consumers seeking healthcare products through its physical pharmacy locations and online services. The firm serves customers needing medicines, dietary supplements, medical equipment, and household healthcare items. Healthlead PCL's business model combines direct retail sales via its branded pharmacies with distribution of health products to various markets. The company focuses on offering a wide range of health-related products under its four pharmacy brands and the PRIME supplement line. Its operations include both the sale of products in-store and the distribution of goods to meet consumer needs for healthcare solutions. Healthlead PCL is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Healthlead PCL stock

Forward P/E Ratio of Healthlead PCL is 25.15 in 2025.

Forward P/E Ratio of Healthlead PCL changed from 25.02 to 25.15, representing a 0.52% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Forward P/E Ratio Healthlead PCL since 2006 – with annual values, charts, and detailed analysis.

The Forward P/E uses estimated future earnings to value a stock. A lower forward P/E relative to the trailing P/E suggests analysts expect earnings growth.

To evaluate Forward P/E Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Forward P/E Ratio.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Forward P/E Ratio's Healthlead PCL with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Healthlead PCL

All Key Metrics — Healthlead PCL